Evolution of the Randomized Clinical Trial in the Era of Precision OncologyJoseph C. Del Paggio, Christopher M. Booth, Elizabeth A. Eisenhauer et al.|JAMA Oncology|2021Cited by 200
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional surveyAdam Fundytus, Christopher M. Booth, Manju Sengar et al.|The Lancet Oncology|2021Cited by 170
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income CountriesJ. Connor Wells, Christopher M. Booth, Shubham Sharma et al.|JAMA Oncology|2021Cited by 165
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworksJoseph C. Del Paggio, Christopher M. Booth, Ian F. Tannock et al.|The Lancet Oncology|2017Cited by 147